Increased glomerular cell heparan sulfates in vitro by ciclosporin A: a Possible explanation of Its beneficial effect in idiopathic nephrotic syndrome

Détails

ID Serval
serval:BIB_5001DC8F2E91
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Increased glomerular cell heparan sulfates in vitro by ciclosporin A: a Possible explanation of Its beneficial effect in idiopathic nephrotic syndrome
Périodique
Nephron
Auteur⸱e⸱s
Birmele  B., De Agostini  A., Girardin  E. P.
ISSN
0028-2766
Statut éditorial
Publié
Date de publication
06/2001
Peer-reviewed
Oui
Volume
88
Numéro
2
Pages
156-62
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Jun
Résumé
BACKGROUND/AIM: In idiopathic nephrotic syndrome (INS), ciclosporin A (CsA) was shown to decrease proteinuria, an effect explained by its immunologic and hemodynamic actions. In order to determine whether CsA could have a direct action on glomerular cells, we studied the effect of CsA on glomerular cells in vitro, particularly on glycosaminoglcycans (GAG) and heparan sulfates (HS) which are decreased in INS patients. METHODS: Human glomerular epithelial cells and rat mesangial cells were cultured at various concentrations of CsA. HS were quantified using a cationic membrane after metabolic labeling. RESULTS: Mesangial cell GAG and HS and epithelial cell HS increased significantly when cells were cultured with CsA. For both cell types this increase was prevailing on the secreted fraction of HS in comparison with the cellular fraction. CsA induced also an increase in cellular cAMP levels, but the effect of CsA was not transduced via a cAMP pathway. CONCLUSIONS: CsA is able to increase glomerular GAG and HS in vitro. As this effect of CsA was the opposite effect on glomerular cells to the effect of plasma from INS patients, we conclude that this direct action of CsA on glomerular cells could explain in part the effect of this drug in decreasing proteinuria in INS.
Mots-clé
Animals Cells, Cultured Cyclic AMP/metabolism Cyclosporine/*pharmacology Glomerular Mesangium/cytology/drug effects/metabolism Glycosaminoglycans/metabolism Heparitin Sulfate/*metabolism Humans Immunosuppressive Agents/*pharmacology Kidney Glomerulus/cytology/drug effects/*metabolism Nephrotic Syndrome/*drug therapy Rats Rats, Sprague-Dawley
Pubmed
Web of science
Création de la notice
15/01/2008 14:28
Dernière modification de la notice
20/08/2019 14:05
Données d'usage